Skip to content

A clinical trial to study effect of Homoeopathy and life style modification in stage I hypertension

Effects of homoeopathic intervention in stage I essential hypertensive patients: a randomized double blind, placebo controlled trial.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/08/015228
Enrollment
217
Registered
2018-08-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Essential hypertension

Interventions

Intervention1: Homoeopathy with life style modification: Individualized homoeopathy along with life style modification for 3 months Control Intervention1: Placebo with life style modifications: Placeb

Sponsors

Central Council for Research in Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. 30 to 60 yrs 2.Both genders 3.Essential hypertension of stage I (SBP 140-159; DBP 90-99) 4.Patients who were not on any anti-hypertensive medicine since last 1 month. 5.Patients willing to participate in the study.

Exclusion criteria

Exclusion criteria: 1.Patients with secondary hypertension of any etiology. 2.Patients with pre hypertension, stage II hypertension as per JNC 7 criteria. 3.Known Diabetics. 4.Patients with a history of myocardial infarction, severe coronary artery disease or clinically significant heart failure or valvular defect or known cases of cardiac diseases. 5.Patients with systemic illness 6.Patients receiving any drugs known to affect blood pressure 7.Patients judged to have a history of alcohol or drug abuse 8.Women who are taking contraceptive pills, pregnancy and lactating mother. 9.Patients suffering from hypothyroidism. 10.Unable or unwilling to give informed consent

Design outcomes

Primary

MeasureTime frame
1 To evaluate the mean change in systolic and diastolic blood pressure from baseline at every month for 3 months from baseline as per routine method. 2 To evaluate the changes in Ambulatory BP at 3rd month from baseline.Timepoint: every month for 3 months

Secondary

MeasureTime frame
Percent of patients meeting the goal BP of SBPâ?¤ 135mmHg and DBP â?¤85 mmHg in patients of both the groupsTimepoint: 3 months

Countries

India

Contacts

Public ContactDr Varanasi Roja

Central Council for Research in Homoeopathy

oberai.praveen@gmail.com011-28525523

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026